Findings could identify aggressive breast cancers that will respond to immunotherapy

by UNC Lineberger Comprehensive Cancer CenterUNC Lineberger’s Charles M. Perou, PhD. Credit: UNCUniversity of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a p

Updated on: March 01,2024

Findings could identify aggressive breast cancers that will respond to immunotherapy

by UNC Lineberger Comprehensive Cancer CenterUNC Lineberger’s Charles M. Perou, PhD. Credit: UNCUniversity of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a p

Updated on:March 01,2024

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Updated on: May 27,2024

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Updated on:May 27,2024

Long-term study finds faster breast cancer radiation treatment as effective as long course

by McMaster UniversityTimothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Re

Updated on: April 18,2024

Long-term study finds faster breast cancer radiation treatment as effective as long course

by McMaster UniversityTimothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Re

Updated on:April 18,2024

Acupressure versus acupuncture—which one is better at treating sleep disturbance in patients with cancer?

byWileyCredit: CC0 Public DomainBoth acupuncture—which is invasive and involves inserted needles—and acupressure—which is non-invasive and involves mechanical pressure—can potentially help reduc

Updated on: January 15,2024

Acupressure versus acupuncture—which one is better at treating sleep disturbance in patients with cancer?

byWileyCredit: CC0 Public DomainBoth acupuncture—which is invasive and involves inserted needles—and acupressure—which is non-invasive and involves mechanical pressure—can potentially help reduc

Updated on:January 15,2024

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Updated on: March 30,2024

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Updated on:March 30,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on: January 15,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on:January 15,2024

Study supports germline testing for all metastatic breast cancer patients

by Tom Wilemon,Vanderbilt University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image c

Updated on: May 25,2024

Study supports germline testing for all metastatic breast cancer patients

by Tom Wilemon,Vanderbilt University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image c

Updated on:May 25,2024

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on: March 09,2024

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on:March 09,2024

CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainA therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impres

Updated on: April 09,2024

CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainA therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impres

Updated on:April 09,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on: May 20,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on:May 20,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024

National cancer control efforts should address the system, not its individual parts, says new report

by National Academy of SciencesCredit: CC0 Public DomainCurrent cancer control efforts in the United States typically are fragmented and uncoordinated, but taking a systems approach to establish

Updated on: May 23,2024

National cancer control efforts should address the system, not its individual parts, says new report

by National Academy of SciencesCredit: CC0 Public DomainCurrent cancer control efforts in the United States typically are fragmented and uncoordinated, but taking a systems approach to establish

Updated on:May 23,2024